Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Aug;73(2):312–315.

Differential immunosuppressive action of carbimazole and propylthiouracil.

R Wilson 1, J H McKillop 1, C Pearson 1, A K Burnett 1, J A Thomson 1
PMCID: PMC1541608  PMID: 3263234

Abstract

Carbimazole and Propylthiouracil (PTU) are widely used in the treatment of Graves' disease, although controversy still exists as to whether or not they have any direct effect on the immune system. While many previous studies have investigated the possible effects of one or other of these drugs on the immune system only a few have directly compared the effects of equivalent doses of each drug. This study aimed to examine the effects of both drugs, during the initial 8 weeks of treatment, on various biochemical and immunological parameters. The results obtained showed that while thyroid hormone levels fell at similar rates in both treatment groups, TRAb levels and T cell subset abnormalities returned towards normal more rapidly in patients receiving Carbimazole compared to PTU. These results indicate that the effects of Carbimazole on TRAb levels and T cell subset abnormalities are not due solely to its action in controlling the biochemical features of Graves' disease and provide indirect evidence of an action on the immune system in vivo.

Full text

PDF
312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Charreire J., Karsenty G., Bouchard P., Schaison G. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease. Clin Exp Immunol. 1984 Sep;57(3):633–638. [PMC free article] [PubMed] [Google Scholar]
  2. Hallengren B., Forsgren A., Melander A. Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab. 1980 Aug;51(2):298–301. doi: 10.1210/jcem-51-2-298. [DOI] [PubMed] [Google Scholar]
  3. Jansson R., Karlsson A., Dahlberg P. A. Thyroxine, methimazole, and thyroid microsomal autoantibody titres in hypothyroid Hashimoto's thyroiditis. Br Med J (Clin Res Ed) 1985 Jan 5;290(6461):11–12. doi: 10.1136/bmj.290.6461.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kendall-Taylor P. Are antithyroid drugs immunosuppressive? Br Med J (Clin Res Ed) 1984 Feb 18;288(6416):509–511. doi: 10.1136/bmj.288.6416.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Knopp R. H., Walden C. E., Wahl P. W., Hoover J. J., Warnick G. R., Albers J. J., Ogilvie J. T., Hazzard W. R. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. J Clin Endocrinol Metab. 1981 Dec;53(6):1123–1132. doi: 10.1210/jcem-53-6-1123. [DOI] [PubMed] [Google Scholar]
  6. Ludgate M. E., McGregor A. M., Weetman A. P., Ratanachaiyavong S., Lazarus J. H., Hall R., Middleton G. W. Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole. Br Med J (Clin Res Ed) 1984 Feb 18;288(6416):526–530. doi: 10.1136/bmj.288.6416.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McGregor A. M., Smith B. R., Hall R., Petersen M. M., Miller M., Dewar P. J. Prediction of relapse in hyperthyroid Graves' disease. Lancet. 1980 May 24;1(8178):1101–1103. doi: 10.1016/s0140-6736(80)91551-2. [DOI] [PubMed] [Google Scholar]
  8. McLachlan S. M., Pegg C. A., Atherton M. C., Middleton S., Young E. T., Clark F., Smith B. R. The effect of carbimazole on thyroid autoantibody synthesis by thyroid lymphocytes. J Clin Endocrinol Metab. 1985 Jun;60(6):1237–1242. doi: 10.1210/jcem-60-6-1237. [DOI] [PubMed] [Google Scholar]
  9. Shewring G., Smith B. R. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) 1982 Oct;17(4):409–417. doi: 10.1111/j.1365-2265.1982.tb01607.x. [DOI] [PubMed] [Google Scholar]
  10. Tötterman T. H., Karlsson F. A., Bengtsson M., Mendel-Hartvig I. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. N Engl J Med. 1987 Jan 1;316(1):15–22. doi: 10.1056/NEJM198701013160104. [DOI] [PubMed] [Google Scholar]
  11. Volpé R., Karlsson A., Jansson R., Dahlberg P. A. Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity. Clin Endocrinol (Oxf) 1986 Oct;25(4):453–462. doi: 10.1111/j.1365-2265.1986.tb01712.x. [DOI] [PubMed] [Google Scholar]
  12. Wenzel K. W., Lente J. R. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs. J Clin Endocrinol Metab. 1984 Jan;58(1):62–69. doi: 10.1210/jcem-58-1-62. [DOI] [PubMed] [Google Scholar]
  13. Wilson R., McKillop J. H., Pearson D. W., Cuthbert G. F., Thomson J. A. Relapse of Graves' disease after medical therapy: predictive value of thyroidal technetium-99m uptake and serum thyroid stimulating hormone receptor antibody levels. J Nucl Med. 1985 Sep;26(9):1024–1028. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES